Gregory K. Chow, Senior VP & CFO at Aptose Biosciences Inc. (APTO), bought 7,500 shares at $1.84 ($14K) on 2019-06-05, disclosed to the SEC on 2019-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| APTO | BUY | 2019-03-14 | $26K | — | Filing → |